menu search

Fulcrum therapeutics announces recent business highlights and financial results for second quarter 2023

screening closed for the Phase 3 REACH pivotal trial of losmapimod in facioscapulohumeral muscular ...

August 3, 2023, 11:01 am

Exact sciences (exas) beats on q2 earnings, ups '23 sales view

Strength in screening revenues and Precision Oncology drive Exact Sciences (EXAS) Q2 performance....

August 2, 2023, 11:57 am

Qgrw: ambitious debut, beats peers since its inception, concerns remain

Passively managed QGRW offers a fresh look at long-duration equity investing by adding capital efficiency screening. QGRW has delivered fairly outstan...

August 2, 2023, 3:05 am

Statement from the prevent cancer foundation on updated guidance for colorectal cancer screening from the american college of physicians

Alexandria, Va., July 31, 2023 (GLOBE NEWSWIRE) — The American College of Physicians (ACP) today issued updated guidance for colorectal cancer scree...

July 31, 2023, 10:13 pm

Growing prevalence of eye diseases and effective diagnosis offered by non-mydriatic fundus camera to boost the global market: future market insights

The global market for non-mydriatic fundus cameras is poised for significant growth, driven by various essential factors. These factors encompass the ...

July 31, 2023, 5:30 pm

Sdvy: top-quality dividend growth mix to consider

SDVY relies on a quality screening process to build a small/mid-cap dividend achievers portfolio. The E...

July 30, 2023, 2:28 pm

The global breast cancer screening tests market is fueled by advancing imaging technologies and biomarker testing, with a projected remarkable cagr of 7.8% by 2033 | future market insights, inc.

NEWARK, Del, July 26, 2023 (GLOBE NEWSWIRE) — Future Market Insights’ latest Global Breast Cancer screenin...

July 26, 2023, 4:30 pm

Icf: etf providing exposure to cohen & steers expertise

The iShares Cohen & Steers REIT ETF provides exposure to a basket of real estate investment trusts (REITs) based on the Cohen & Steers Realty Majors I...

July 24, 2023, 3:14 am

Ipo update: advanced biomed finalizes $112 million u.s. ipo plan

Advanced Biomed has filed proposed terms for a $112 million U.S. IPO. The firm is developing a portfolio of cancer ...

July 19, 2023, 1:25 pm

Seamless screening! full body scanners offer efficient and non-intrusive security measures future market insights predicts the industry to have a cagr of 9.7% by 2033

According to a recent market study by Future Market Insights, the Full Body Scanner market expansion is driven by integrating artificial intelligence ...

July 18, 2023, 11:30 am

Predictmedix to change its name to align with ai image

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced that it will be changing its corporate name to Predictmedix AI Inc, aligning the company's bra...

July 10, 2023, 8:11 am

Looking for biotech ai stocks? 3 names that will benefit from the ai boom

AI is coming to biotech in a big way. From protein folding to drug screening, from studying cells to studying populations, the AI boom has long been a...

July 8, 2023, 8:43 pm

5 best peg-driven garp stocks for investors

Here are the five stocks that fit our screening criteria, TOL, PDCO, GEF, NXST and AFYA....

July 3, 2023, 9:57 am

Flight delays mar record holiday air travel. why airline stocks are alright.

Friday was the busiest ever air travel day in the U.S., with the Transportation Security Administration screen...

July 3, 2023, 8:34 am

Ai-based health screening company ihealthscreen announces q&a webinar

iHealthScreen is an AI-driven, HIPAA-compliant medtech company with incoming product traction in several international markets, using AI to scalably s...

June 27, 2023, 7:16 pm

Ai-based health screening company ihealthscreen reaches $150k in investments

iHealthScreen is an AI-driven, HIPAA-compliant medtech company with incoming product traction in several international markets, using AI to scalably s...

June 27, 2023, 12:25 am

Analysts bullish on exact sciences' advanced cancer screening

Exact Sciences Corp. NASDAQ: EXAS is on a self-proclaimed mission to change the way cancer is detected and treated. The Madison, Wisconsin company is ...

June 23, 2023, 7:10 am

Colposcopy market size to hit usd 0.86 billion by 2030 at 5.12% cagr – report by market research future (mrfr)

Colposcopy Market Trends and Insights By Instrument Type (Optical Colposcope, Digital Colposcope), Instrument Portability (Portable, Fixed, Handheld),...

June 22, 2023, 12:49 am

Exact sciences shares gain on results from non-invasive cancer screening test

Shares of Exact Sciences Corp. EXAS, +0.98% gained more than 7% in premarket trading Wednesday after the company released results from a study of its ...

June 21, 2023, 8:18 am

Exact sciences set to rally on positive top-line results from pivotal blue-c study

Exact Sciences (NASDAQ:EXAS) shares rose in Wednesday pre-market trading after the molecular diagnostics company specializing in the detection of earl...

June 21, 2023, 8:14 am


Search within

Pages Search Results: